A retrospective chart review compared the difference in outcomes between Black patients and White patients with advanced RCC for 3 first-line therapies.

Both dose levels of modakafusp alfa “resulted in good response rates with similar safety profiles,” according to researchers.

The objective response rate was 78.6% in the overall cohort, 76.9% in patients with a PD-L1 combined positive score (CPS) below 1, 68.8% in patients with a PD-L1 CPS of 1-9, and 100% in patients with ...

Study results “provide strong support for integrating symptom screening and care pathways into routine clinical care,” according to researchers ...

Greatest increases in early-onset colorectal cancer incidence rates seen in New Zealand, Chile, Puerto Rico, and England.

Researchers sought to determine if HRQoL measures differ with gilteritinib compared with placebo in patients with AML.